or Try an Advanced Search...

    Technical Analysis for DXB - Dimerix Ltd  

    Grade Last Price % Change Price Change
    F 0.395 5.33% 0.020
    DXB closed down 2.6 percent on Thursday, November 7, 2024, on 77 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical DXB trend table...
    Date Alert Name Type % Chg
    Fell Below 200 DMA Bearish 5.33%
    Wide Bands Range Expansion 5.33%
    Oversold Stochastic Weakness 5.33%
    Crossed Above 200 DMA Bullish 2.60%
    Stochastic Buy Signal Bullish 2.60%
    NR7 Range Contraction 2.60%
    Narrow Range Bar Range Contraction 2.60%
    Inside Day Range Contraction 2.60%
    Wide Bands Range Expansion 2.60%
    Oversold Stochastic Weakness 2.60%
    Older End-of-Day Signals for DXB ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR about 2 hours ago
    Rose Above Previous Day's High about 3 hours ago
    Rose Above 10 DMA about 3 hours ago
    Up 5% about 3 hours ago
    Up 3% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DXB Chart by TradingView
    Basic chart:

    Profile

    Dimerix Bioscience Ltd, formerly Dimerix Bioscience Pty Ltd, is engaged in developing and commercializing drug therapies and drug discovery tools. The Company’s business activity focuses on the clinical development of the Company’s therapeutic product (DMX200), which is targeted at treatind patients with chronic kidney disease; the development of other therapeutic oppurtunities generated from the use of its cell-based drug discovery assay technology (know as Receptor-HIT), and growing its assay business through the use of Receptor-HIT to assist third parties in their own drug discovery and development processes through contract research. DMX200 is a therapeutic approach to treating chronic kidney disease. It comprises two drugs: irbesartan and propagermanium.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Disease Drugs Life Sciences Health Sciences Drug Discovery Therapeutic Product

    Is DXB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 31 Dimerix Full Year 2024 Earnings: AU$0.038 loss per share (vs AU$0.042 loss in FY 2023)
    May 27 Dimerix and Taiba enter DMX-200 commercialisation deal in Middle East
    May 23 Dimerix (ASX:DXB) shareholders have earned a 359% return over the last year
    See more DXB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.665
    52 Week Low 0.13
    Average Volume 2,378,374
    200-Day Moving Average 0.383
    50-Day Moving Average 0.410
    20-Day Moving Average 0.427
    10-Day Moving Average 0.397
    Average True Range 0.024
    RSI (14) 39.02
    ADX 13.92
    +DI 17.602
    -DI 22.707
    Chandelier Exit (Long, 3 ATRs) 0.438
    Chandelier Exit (Short, 3 ATRs) 0.442
    Upper Bollinger Bands 0.502
    Lower Bollinger Band 0.352
    Percent B (%b) 0.15
    BandWidth 35.269
    MACD Line -0.010
    MACD Signal Line -0.003
    MACD Histogram -0.007
    Fundamentals Value
    Market Cap 74.2 Million
    Num Shares 198 Million
    EPS -0.02
    Price-to-Earnings (P/E) Ratio -20.83
    Price-to-Sales 0.00
    Price-to-Book 6.25
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.405
    Resistance 3 (R3) 0.407 0.398 0.400
    Resistance 2 (R2) 0.398 0.391 0.398 0.398
    Resistance 1 (R1) 0.387 0.386 0.383 0.385 0.397
    Pivot Point 0.378 0.378 0.376 0.378 0.378
    Support 1 (S1) 0.367 0.371 0.363 0.365 0.353
    Support 2 (S2) 0.358 0.366 0.358 0.352
    Support 3 (S3) 0.347 0.358 0.350
    Support 4 (S4) 0.345